PTC THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ptc Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Ptc Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$54.5M, a 53.9% increase year-over-year.
  • Ptc Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$134M, a 79.2% increase year-over-year.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$440M, a 1.77% increase from 2022.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$447M, a 19.5% decline from 2021.
  • Ptc Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$374M, a 13.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$134M -$54.5M +$63.7M +53.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$198M -$40.2M +$169M +80.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$367M -$45.5M +$72.2M +61.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$440M $5.82M +$206M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$646M -$118M -$50M -73.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$596M -$210M -$117M -127% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$479M -$118M -$31.1M -35.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$447M -$200M -$116M -136% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$332M -$68.2M +$24.9M +26.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$357M -$92.4M +$6.13M +6.23% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$363M -$86.5M +$11.6M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$374M -$84.7M +$11.6M +12.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$386M -$93.1M -$37.9M -68.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$348M -$98.5M +$88.8M +47.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$437M -$98.1M -$5.16M -5.55% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$432M -$96.4M -$23.6M -32.4% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$408M -$55.1M +$5.34M +8.84% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$414M -$187M -$149M -383% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$265M -$93M -$23.9M -34.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$241M -$72.8M -$27.6M -61.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$214M -$60.5M -$12.2M -25.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$201M -$38.8M -$33.2M -595% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$168M -$69.1M -$52.4M -313% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$116M -$45.1M -$50.6M -928% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$65.1M -$48.2M -$17.3M -56.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$47.8M -$5.57M +$6.92M +55.4% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$54.7M -$16.7M +$9.61M +36.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$64.3M $5.45M +$30.4M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$94.7M -$30.9M +$1.17M +3.66% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$95.9M -$12.5M +$24.1M +65.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$120M -$26.4M +$12.1M +31.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$132M -$25M +$23.2M +48.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$155M -$32.1M +$10.2M +24.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$165M -$36.6M +$2.07M +5.35% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$168M -$38.4M -$371K -0.97% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$167M -$48.2M -$16M -49.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$151M -$42.2M -$14.6M -53% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$137M -$38.6M -$13.3M -52.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$123M -$38.1M -$23.9M -168% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$99.4M -$32.2M -$14.1M -78.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$85.3M -$27.6M -$23.3M -545% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$62M -$25.4M -$10.9M -75.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$51M -$14.2M -$5.64M -65.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$45.4M -$18.1M -$12.1M -200% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$33.3M -$4.28M +$2.78M +39.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$36.1M -$14.5M -$6.95M -92.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$29.2M -$8.58M -$2.36M -37.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 -$26.8M -$6.03M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$7.06M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-06
Q2 2012 -$7.5M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-06
Q1 2012 -$6.22M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.